Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate E Lawlor

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|March 18, 2003
Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activationPaul J Egan, Kate E Lawlor, Warren S Alexander, et al.
Trends in Immunology|November 26, 2025
Get with the program: regulation of T cell deathTimothy Patton, Hosna Sarani, Nazli Somuncuoglu, et al.
Biomolecules|April 30, 2021
Targeting RIP Kinases in Chronic Inflammatory DiseaseMary Speir, Tirta M Djajawi, Stephanie A Conos, et al.
Cell Death & Disease|June 20, 2020
The pro-survival Bcl-2 family member A1 delays spontaneous and FAS ligand-induced apoptosis of activated neutrophilsRobyn L Schenk, Lahiru Gangoda, Kate E Lawlor, et al.
Arthritis and Rheumatism|December 2, 2005
Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factorKate E Lawlor, Peter K K Wong, Ian K Campbell, et al.
Journal of Leukocyte Biology|July 2, 2011
Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritisKate E Lawlor, Scott D Smith, Annemarie van Nieuwenhuijze, et al.
Cell Reports|February 10, 2018
IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial PeptidoglycansChe A Stafford, Kate E Lawlor, Valentin J Heim, et al.
British Journal of Pharmacology|July 5, 2019
Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infectionSarah Rosli, Francis J Kirby, Kate E Lawlor, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2004
Critical role for granulocyte colony-stimulating factor in inflammatory arthritisKate E Lawlor, Ian K Campbell, Donald Metcalf, et al.
Cell Death & Disease|November 9, 2023
Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infectionSarah Rosli, Christopher M Harpur, Maggie Lam, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|March 18, 2003
Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activationPaul J Egan, Kate E Lawlor, Warren S Alexander, et al.
Trends in Immunology|November 26, 2025
Get with the program: regulation of T cell deathTimothy Patton, Hosna Sarani, Nazli Somuncuoglu, et al.
Biomolecules|April 30, 2021
Targeting RIP Kinases in Chronic Inflammatory DiseaseMary Speir, Tirta M Djajawi, Stephanie A Conos, et al.
Cell Death & Disease|June 20, 2020
The pro-survival Bcl-2 family member A1 delays spontaneous and FAS ligand-induced apoptosis of activated neutrophilsRobyn L Schenk, Lahiru Gangoda, Kate E Lawlor, et al.
Arthritis and Rheumatism|December 2, 2005
Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factorKate E Lawlor, Peter K K Wong, Ian K Campbell, et al.
Journal of Leukocyte Biology|July 2, 2011
Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritisKate E Lawlor, Scott D Smith, Annemarie van Nieuwenhuijze, et al.
Cell Reports|February 10, 2018
IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial PeptidoglycansChe A Stafford, Kate E Lawlor, Valentin J Heim, et al.
British Journal of Pharmacology|July 5, 2019
Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infectionSarah Rosli, Francis J Kirby, Kate E Lawlor, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2004
Critical role for granulocyte colony-stimulating factor in inflammatory arthritisKate E Lawlor, Ian K Campbell, Donald Metcalf, et al.
Cell Death & Disease|November 9, 2023
Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infectionSarah Rosli, Christopher M Harpur, Maggie Lam, et al.
Pageof 7